Table 2.
Typical symptoms and their severity claimed by the patients at the five visit categories
| Visit 1 | Diagnostics (Day 0). n of cases = 236 | |||
|---|---|---|---|---|
| Typical symptoms | Total (%) | Mild (%) | Moderate (%) | Severe (%) |
| Urinary frequency | 210 (88.98%) | 69 (29.24%) | 69 (29.24%) | 72 (30.51%) |
| Urinary urgency | 220 (93.22%) | 40 (16.95%) | 88 (37.29%) | 92 (38.98%) |
| Dysuria | 229 (97.03%) | 38 (16.10%) | 72 (30.51%) | 119 (50.42%) |
| Suprapubic pain | 196 (83.05%) | 62 (26.27%) | 83 (35.17%) | 51 (21.61%) |
| Incomplete bladder emptying | 218 (92.37%) | 62 (26.27%) | 89 (37.71%) | 67 (28.39%) |
| Visible blood in urine | 82 (34.75%) | 43 (18.22%) | 21 (8.90%) | 18 (7.63%) |
| Visit 2 | Very early FU visit (in less than 2 days). n of cases = 23 | |||
|---|---|---|---|---|
| Typical symptoms | Total (%) | Mild (%) | Moderate (%) | Severe (%) |
| Urinary frequency | 18 (78.26%) | 10 (43.48%) | 5 (21.74%) | 3 (13.04%) |
| Urinary urgency | 22 (95.65%) | 13 (56.52%) | 8 (34.78%) | 1 (4.35%) |
| Dysuria | 22 (95.65%) | 5 (21.74%) | 12 (52.17%) | 5 (21.74%) |
| Suprapubic pain | 18 (78.26%) | 8 (34.78%) | 6 (26.09%) | 4 (17.39%) |
| Incomplete bladder emptying | 19 (82.61%) | 8 (34.78%) | 8 (34.78%) | 3 (13.04%) |
| Visible blood in urine | 4 (27.39%) | 2 (8.70%) | 1 (4.35%) | 1 (4.35%) |
| Visit 3 | Early FU visit (2–4 days). n of cases = 97 | |||
|---|---|---|---|---|
| Typical symptoms | Total (%) | Mild (%) | Moderate (%) | Severe (%) |
| Urinary frequency | 42 (43.30%) | 28 (28.87%) | 12 (12.37%) | 2 (2.06%) |
| Urinary urgency | 51 (52.58%) | 36 (37.11%) | 13 (13.40%) | 2 (2.06%) |
| Dysuria | 59 (60.82%) | 40 (41.24%) | 14 (14.43%) | 5 (5.15%) |
| Suprapubic pain | 49 (50.52%) | 32 (32.99%) | 10 (10.31%) | 7 (7.22%) |
| Incomplete bladder emptying | 50 (51.55%) | 38 (39.18%) | 9 (9.28%) | 3 (3.09%) |
| Visible blood in urine | 13 (13.40%) | 8 (8.25%) | 4 (4.12%) | 1 (1.03%) |
| Visit 4 | End-of-treatment FU visit (5–9 days). n of cases = 82 | |||
|---|---|---|---|---|
| Typical symptoms | Total (%) | Mild (%) | Moderate (%) | Severe (%) |
| Urinary frequency | 24 (29.27%) | 16 (19.51%) | 7 (8.54%) | 1 (1.22%) |
| Urinary urgency | 33 (40.24%) | 26 (31.71%) | 6 (7.32%) | 1 (1.22%) |
| Dysuria | 37 (45.12%) | 33 (40.24%) | 3 (3.66%) | 1 (1.22%) |
| Suprapubic pain | 24 (29.27%) | 19 (23.17%) | 3 (3.66%) | 2 (2.44%) |
| Incomplete bladder emptying | 28 (34.15%) | 21 (25.61%) | 7 (8.54%) | 0 (0.00%) |
| Visible blood in urine | 2 (2.44%) | 1 (1.22%) | 1 (1.22%) | 0 (0.00%) |
| Visit 5 | Test-of-cure visit (10–30 days). n of cases = 34 | |||
|---|---|---|---|---|
| Typical symptoms | Total (%) | Mild (%) | Moderate (%) | Severe (%) |
| Urinary frequency | 14 (41.28%) | 12 (35.29%) | 1 (2.94%) | 1 (2.94%) |
| Urinary urgency | 14 (41.28%) | 12 (35.29%) | 1 (2.94%) | 1 (2.94%) |
| Dysuria | 15 (44.12%) | 12 (35.29%) | 3 (8.82%) | 0 (0.00%) |
| Suprapubic pain | 6 (17.65%) | 5 (14.71%) | 1 (2.94%) | 0 (0.00%) |
| Incomplete bladder emptying | 8 (23.53%) | 6 (17.65%) | 1 (2.94%) | 1 (2.94%) |
| Visible blood in urine | 2 (5.88%) | 2 (5.88%) | 0 (0.00%) | 0 (0.00%) |